BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24688106)

  • 1. Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.
    Fend F; Quintanilla-Martínez L
    Haematologica; 2014 Apr; 99(4):599-602. PubMed ID: 24688106
    [No Abstract]   [Full Text] [Related]  

  • 2. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.
    Sander B; de Jong D; Rosenwald A; Xie W; Balagué O; Calaminici M; Carreras J; Gaulard P; Gribben J; Hagenbeek A; Kersten MJ; Molina TJ; Lee A; Montes-Moreno S; Ott G; Raemaekers J; Salles G; Sehn L; Thorns C; Wahlin BE; Gascoyne RD; Weller E
    Haematologica; 2014 Apr; 99(4):715-25. PubMed ID: 24510338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good prognosis for follicular lymphoma with estrogen receptor α-positive follicular dendritic cells.
    Ohe R; Meng HX; Yamada A; Ye Aung N; Kabasawa T; Tamura Y; Utsunomiya A; Tamazawa N; Kawamura I; Kitaoka T; Suzuki K; Yanagiya R; Toubai T; Ishizawa K; Yamakawa M
    Hematol Oncol; 2020 Aug; 38(3):293-300. PubMed ID: 32196124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Update on relation between follicular helper T cells and lymphoma].
    Li WS; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):634-7. PubMed ID: 24314256
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers.
    van den Brand M; Mathijssen JJ; Garcia-Garcia M; Hebeda KM; Groenen PJ; Falini B; Serrano S; van Krieken JH
    Haematologica; 2015 Sep; 100(9):e358-60. PubMed ID: 26069292
    [No Abstract]   [Full Text] [Related]  

  • 6. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
    Szumera-Ciećkiewicz A; Poleszczuk J; Kuczkiewicz-Siemion O; Paszkiewicz-Kozik E; Rymkiewicz G; Sokół K; Borysiuk A; Kotarska M; Kawecka M; Owczarek D; Pytlak B; Walewski J; Prochorec-Sobieszek M
    Pathol Res Pract; 2020 Oct; 216(10):153096. PubMed ID: 32853965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.
    de Jong D; Koster A; Hagenbeek A; Raemaekers J; Veldhuizen D; Heisterkamp S; de Boer JP; van Glabbeke M
    Haematologica; 2009 Jan; 94(1):70-7. PubMed ID: 19059937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular origin of a subset of CD5(+) diffuse large B-cell lymphomas.
    Catherwood MA; Venkatraman L
    Am J Clin Pathol; 2006 Jun; 125(6):954-5. PubMed ID: 16761357
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone Marrow Infiltration of Angioimmunoblastic T-Cell Lymphoma: Identification and Prognostic Impact of Histologic Patterns and Diagnostic Application of Ancillary Phenotypic and Molecular Analyses.
    Gerlach MM; Juskevicius D; Vela V; Dirnhofer S; Tzankov A
    Arch Pathol Lab Med; 2020 May; 144(5):602-611. PubMed ID: 31556696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Biological Basis of Histologic Transformation.
    Kumar EA; Okosun J; Fitzgibbon J
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):771-784. PubMed ID: 32586580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicobiological, prognostic and therapeutic implications of the tumor microenvironment in follicular lymphoma.
    Lejeune M; Alvaro T
    Haematologica; 2009 Jan; 94(1):16-21. PubMed ID: 19118376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
    Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
    Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
    Bararia D; Hildebrand JA; Stolz S; Haebe S; Alig S; Trevisani CP; Osorio-Barrios F; Bartoschek MD; Mentz M; Pastore A; Gaitzsch E; Heide M; Jurinovic V; Rautter K; Gunawardana J; Sabdia MB; Szczepanowski M; Richter J; Klapper W; Louissaint A; Ludwig C; Bultmann S; Leonhardt H; Eustermann S; Hopfner KP; Hiddemann W; von Bergwelt-Baildon M; Steidl C; Kridel R; Tobin JWD; Gandhi MK; Weinstock DM; Schmidt-Supprian M; Sárosi MB; Rudelius M; Passerini V; Mautner J; Weigert O
    Cell Rep; 2020 May; 31(5):107522. PubMed ID: 32330423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual case of follicular lymphoma with hyaline-vascular follicles.
    Nozawa Y; Hirao M; Kamimura K; Hara Y; Abe M
    Pathol Int; 2002 Dec; 52(12):794-5. PubMed ID: 12588450
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
    Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.
    Smeltzer JP; Jones JM; Ziesmer SC; Grote DM; Xiu B; Ristow KM; Yang ZZ; Nowakowski GS; Feldman AL; Cerhan JR; Novak AJ; Ansell SM
    Clin Cancer Res; 2014 Jun; 20(11):2862-72. PubMed ID: 24727328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma.
    Krishnadasan R; Bifulco C; Kim J; Rodov S; Zieske AW; Vanasse GJ
    Br J Haematol; 2006 Oct; 135(1):72-5. PubMed ID: 16939500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis in low-grade follicular lymphoma - a link to the TH2 immune reaction.
    Lohneis P; Wienert S; Klauschen F; Anagnostopoulos I; Jöhrens K
    Leuk Lymphoma; 2017 May; 58(5):1190-1196. PubMed ID: 27736316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of MUM-1/IRF4 protein expression in follicular lymphoma].
    Huo YY; Pan Y; Guan BX; Fang AJ; Sun BC; Zhou GY; Fu K; Meng B
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):528-31. PubMed ID: 22169641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.